1572-靶向外周5-HT2AR增强结直肠癌抗肿瘤免疫 episode artwork

EPISODE · Sep 13, 2026 · 29 MIN

1572-靶向外周5-HT2AR增强结直肠癌抗肿瘤免疫

from 聊聊Sci

这项研究揭示了外周血清素受体 5-HT2AR 在调控结直肠癌抗肿瘤免疫中的新机制。研究人员发现,虽然传统幻觉剂 LSD 能抑制肿瘤生长,但其成瘾和致幻副作用限制了临床应用。为此,团队开发了名为 IHCH-8110 的新型激动剂,该药物不进入大脑,从而在避免幻觉效果的同时,专一激活肠道中的肠神经胶质细胞。这种激活促使胶质细胞释放关键细胞因子,进而招募并增强 CD8+ T细胞 对肿瘤的杀伤能力。实验证明,该疗法能显著提升免疫检查点阻断(如 PD-1 抗体)的疗效,为治疗对免疫疗法不敏感的“冷肿瘤”提供了全新的策略。References:Wen Y T, Tang L J, Duan W W, et al. Targeting peripheral 5-HT2AR enhances antitumor immunity in colorectal cancer[J]. Cell, 2026.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Sep 13, 2026

Embed this episode

Ready to play

1572-靶向外周5-HT2AR增强结直肠癌抗肿瘤免疫

0:00 29:58

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 29 minutes long.

When was this 聊聊Sci episode published?

This episode was published on September 13, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!